HPV Clinical Trials 2024

HPV Clinical Trials 2024

HPV research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in human papillomavirus clinical trials today.

Trials for OPC Patients

Trials for P16 Positive Patients

Trials for HPV Positive Patients

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to hpv

What are the top hospitals conducting hpv research?

When it comes to clinical trials focused on HPV, several hospitals are leading the charge in advancing our understanding and treatment of this prevalent virus. The National Institutes of Health Clinical Center in Bethesda stands out as a notable institution with four active HPV trials currently underway. With five total trials conducted since their first recorded trial in 2017, they have been at the forefront of research into this virus that affects millions worldwide.

In Rochester, Minnesota, the renowned Mayo Clinic is actively involved in three ongoing HPV trials. While they do not have any previous recorded HPV trials to their name, their dedication to exploring new avenues for treating and preventing this virus is commendable.

Meanwhile, Acevedo Clinical Research Associates (Site 0001) in Miami has made significant contributions to HPV research by conducting two active trials and having completed two additional studies since embarking on their first trial in 2020. Their commitment to finding innovative solutions for those affected by HPV highlights the importance placed on addressing this pressing health concern.

In Chicago's Anal Dysplasia Clinic MidWest, researchers are actively engaged in two ongoing clinical trials focusing on HPV. Although they do not possess any prior recorded HPV studies, their current efforts demonstrate a dedication towards furthering knowledge about this virus and its potential impact on individuals' health.

Lastly from New york City where Laser Surgery Care contributes significantly through participating in two current HPv testing while leaving no trail previously; laser surgery care prioritizes providing exceptional healthcare services imbued with advanced technology aimed at aiding patients battling Hpv infections. Through these collaborative efforts across various locations nationwide,it becomes evident that medical professionals are dedicating themselves tirelessly to develop novel approaches againstHPV.Moreover,hospitals embracing these initiatives signify a beaconof hopefor individuals grapplingwiththeimplicationsandintricaciesofHPVinfections.Through such ambitious ventures,better treatmentsandpreventive measuresarebeing pursued,resultingin abrighterfutureforallthoseaffectedbythisglobal healthconcern.

Which are the best cities for hpv clinical trials?

When it comes to HPV clinical trials, several cities have emerged as leaders in research and development. New york leads the pack with 8 active trials focused on studying treatments like the 9vHPV Vaccine and laboratory biomarker analysis. Miami closely follows with 6 ongoing studies examining interventions such as the 9vHPV Vaccine and Cisplatin. Bethesda and Houston tie for third place, each hosting 5 active trials exploring various treatments including PRGN-2012 and Cemiplimab. Lastly, Tucson boasts 4 active trials investigating options like Recombinant Human Papillomavirus Nonavalent Vaccine. These cities offer individuals participating in HPV clinical trials access to cutting-edge research that contributes to advancements in care for this prevalent virus.

Which are the top treatments for hpv being explored in clinical trials?

In the realm of HPV research, one treatment stands out as a frontrunner in clinical trials. The 9vHPV vaccine has caught the attention of researchers with its potential to combat this prevalent virus. Currently, there are two active trials dedicated to exploring its effectiveness. Since its introduction in 2020, it has been part of three all-time HPV trials, showcasing promising advancements in our fight against this pervasive infection. As scientists delve deeper into understanding and treating HPV, the 9vHPV vaccine holds great promise for improving outcomes and preventing related diseases worldwide

What are the most recent clinical trials for hpv?

Exciting developments are occurring in the field of HPV research, with recent clinical trials exploring promising avenues for treatment and prevention. One such trial investigates Arm 1, a Phase 2 study aimed at evaluating new therapeutic approaches to combat HPV infections. Additionally, Nitric Oxide Releasing Solution 2X is being examined in a Phase 2 trial as a potential intervention against HPV. Another trial focuses on Dose Escalation in its Phase 1 stage, assessing the safety and efficacy of various dosage levels for treating HPV-related conditions. Meanwhile, an advanced combined Phase 2/Phase 3 study is underway to assess the effectiveness of an innovative HPV vaccine. Finally, E7 TCR-T cells are being investigated in a Phase 2 trial as another possible avenue for combating HPV infection. These ongoing trials offer hope for improved outcomes among individuals affected by this prevalent virus

What hpv clinical trials were recently completed?

Recently, several clinical trials focused on Human Papillomavirus (HPV) have reached completion, bringing new insights and potential advancements to the field. These trials represent significant efforts in understanding and combating HPV-related diseases. Notably, a trial sponsored by the National Cancer Institute successfully concluded in September 2021. While specific details about this particular trial are not provided here, it is an important contribution to the ongoing battle against HPV and its associated conditions. The research community's commitment to finding innovative solutions for preventing and treating HPV continues to drive progress in this area of healthcare.